3 false false false false false false false false false false true false false false false false false No description of principal activity 2024-10-01 Sage Accounts Production Advanced 2024 - FRS102_2024 850,000 850,000 850,000 xbrli:pure xbrli:shares iso4217:GBP 09472891 2024-10-01 2025-09-30 09472891 2025-09-30 09472891 2024-09-30 09472891 2023-10-01 2024-09-30 09472891 2024-09-30 09472891 2023-09-30 09472891 bus:LeadAgentIfApplicable 2024-10-01 2025-09-30 09472891 bus:Director1 2024-10-01 2025-09-30 09472891 bus:Director2 2024-10-01 2025-09-30 09472891 bus:Director3 2024-10-01 2025-09-30 09472891 core:AfterOneYear 2025-09-30 09472891 core:AfterOneYear 2024-09-30 09472891 core:WithinOneYear 2025-09-30 09472891 core:WithinOneYear 2024-09-30 09472891 core:ShareCapital 2025-09-30 09472891 core:ShareCapital 2024-09-30 09472891 core:CostValuation core:Non-currentFinancialInstruments 2025-09-30 09472891 core:Non-currentFinancialInstruments 2025-09-30 09472891 core:Non-currentFinancialInstruments 2024-09-30 09472891 bus:SmallEntities 2024-10-01 2025-09-30 09472891 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 09472891 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 09472891 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 09472891 bus:FullAccounts 2024-10-01 2025-09-30 09472891 core:AllSubsidiaries 2025-09-30
COMPANY REGISTRATION NUMBER: 09472891

Celltex Holdings Limited

Filleted Unaudited Financial Statements

30 September 2025

Celltex Holdings Limited

Financial Statements

Year Ended 30th September 2025

Contents | Page

Chartered Certified Accountants Report to the Board of Directors on the Preparation of the Unaudited Statutory Financial Statements | 1

Statement of Financial Position | 2

Notes to the Financial Statements | 4

Celltex Holdings Limited

Chartered Certified Accountants Report to the Board of Directors on the Preparation of the Unaudited Statutory Financial Statements of Celltex Holdings Limited

Year Ended 30th September 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Celltex Holdings Limited for the year ended 30th September 2025, which comprise the statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at www.accaglobal.com/en/member/professional-standards/rules-standards/acca-rulebook.html. This report is made solely to the Board of Directors of Celltex Holdings Limited, as a body, in accordance with the terms of our engagement letter dated 7th September 2021. Our work has been undertaken solely to prepare for your approval the financial statements of Celltex Holdings Limited and state those matters that we have agreed to state to you, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Celltex Holdings Limited and its Board of Directors, as a body, for our work or for this report.
It is your duty to ensure that Celltex Holdings Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Celltex Holdings Limited. You consider that Celltex Holdings Limited is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the financial statements of Celltex Holdings Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
MJ GREEN ACCOUNTANCY SERVICES LTD Chartered Certified Accountants
Unit 10 Silver End Business Park Brettell Lane Brierley Hill West Midlands DY5 3LG
13 April 2026

Celltex Holdings Limited

Statement of Financial Position

30 September 2025

| 2025 | 2024
Note | £ | £

Fixed Assets

Investments | 5 | 850,000 | 850,000

Current Assets

Debtors | 6 | 300 | 300

Creditors: amounts falling due within one year | 7 | 41,000 | 41,000
| -------- | --------
Net Current Liabilities | 40,700 | 40,700
| --------- | ---------
Total Assets Less Current Liabilities | 809,300 | 809,300

Creditors: amounts falling due after more than one year | 8 | 809,000 | 809,000
| --------- | ---------
Net Assets | 300 | 300
| --------- | ---------

Capital and Reserves

Called up share capital | 300 | 300
| ---- | ----
Shareholders Funds | 300 | 300
| ---- | ----

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30th September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Celltex Holdings Limited

Statement of Financial Position (continued)

30 September 2025
These financial statements were approved by the board of directors and authorised for issue on 13 April 2026 , and are signed on behalf of the board by:

S P Evans | A N Foggin
Director | Director

A D W Dalziel |
Director |

Company registration number: 09472891

Celltex Holdings Limited

Notes to the Financial Statements

Year Ended 30th September 2025
1. General Information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 12, Block 3, Wednesbury Trading Estate, Wednesbury, West Midlands, WS10 7JN.
2. Statement of Compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting Policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
4. Employee Numbers
The average number of persons employed by the company during the year amounted to 3 (2024: 3 ).
5. Investments

| Shares in group undertakings
| £
Cost |
At 1st October 2024 and 30th September 2025 | 850,000
| ---------
Impairment |
At 1st October 2024 and 30th September 2025 | –
| ---------

Carrying amount |
At 30th September 2025 | 850,000
| ---------
At 30th September 2024 | 850,000
| ---------

6. Debtors

| 2025 | 2024
| £ | £
Other debtors | 300 | 300
| ---- | ----

7. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Other creditors | 41,000 | 41,000
| -------- | --------

8. Creditors: amounts falling due after more than one year

| 2025 | 2024
| £ | £
Amounts owed to group undertakings and undertakings in which the company has a participating interest | 809,000 | 809,000
| --------- | ---------

9. Related Party Transactions
During the year Celltex Limited, a company in which S P Evans , A N Foggin and A D W Dalziel are directors, provided an interest free loan to the company. The amount outstanding at 30th September 2025 amounted to £ 809,000 (2024 - £809,000). During the year the company received dividends amounting to £124,500 (2023 - £90,000) from Celltex Limited, a company in which S P Evans , A N Foggin and A D W Dalziel are directors.